Drug Interactions
Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.
Browse the pages below for detailed information.
vibegron — β3-adrenoceptor Interaction
Drug-target interaction between vibegron and β3-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
vigabatrin — 4-aminobutyrate aminotransferase Interaction
Drug-target interaction between vigabatrin and 4-aminobutyrate aminotransferase. Synthetic organic pharmacological agent targeting this protein.
vilanterol — β2-adrenoceptor Interaction
Drug-target interaction between vilanterol and β2-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
vilazodone — 5-HT1A receptor Interaction
Drug-target interaction between vilazodone and 5-HT1A receptor. Synthetic organic pharmacological agent targeting this protein.
vilazodone — SERT Interaction
Drug-target interaction between vilazodone and SERT. Synthetic organic pharmacological agent targeting this protein.
vildagliptin — dipeptidyl peptidase 4 Interaction
Drug-target interaction between vildagliptin and dipeptidyl peptidase 4. Synthetic organic pharmacological agent targeting this protein.
vinblastine — tubulin beta class I Interaction
Drug-target interaction between vinblastine and tubulin beta class I. Synthetic organic pharmacological agent targeting this protein.
vincristine — tubulin beta class I Interaction
Drug-target interaction between vincristine and tubulin beta class I. Natural product pharmacological agent targeting this protein.
vismodegib — SMO Interaction
Drug-target interaction between vismodegib and SMO. Synthetic organic pharmacological agent targeting this protein.
voclosporin — peptidylprolyl isomerase A Interaction
Drug-target interaction between voclosporin and peptidylprolyl isomerase A. Peptide pharmacological agent targeting this protein.
vorapaxar — PAR1 Interaction
Drug-target interaction between vorapaxar and PAR1. Synthetic organic pharmacological agent targeting this protein.
vorinostat — histone deacetylase 1 Interaction
Drug-target interaction between vorinostat and histone deacetylase 1. Synthetic organic pharmacological agent targeting this protein.
vornorexant — OX1 receptor Interaction
Drug-target interaction between vornorexant and OX1 receptor. Synthetic organic pharmacological agent targeting this protein.
vornorexant — OX2 receptor Interaction
Drug-target interaction between vornorexant and OX2 receptor. Synthetic organic pharmacological agent targeting this protein.
vortioxetine — 5-HT1A receptor Interaction
Drug-target interaction between vortioxetine and 5-HT1A receptor. Synthetic organic pharmacological agent targeting this protein.
vortioxetine — 5-HT1B receptor Interaction
Drug-target interaction between vortioxetine and 5-HT1B receptor. Synthetic organic pharmacological agent targeting this protein.
vortioxetine — 5-HT7 receptor Interaction
Drug-target interaction between vortioxetine and 5-HT7 receptor. Synthetic organic pharmacological agent targeting this protein.
vortioxetine — SERT Interaction
Drug-target interaction between vortioxetine and SERT. Synthetic organic pharmacological agent targeting this protein.
warfarin — vitamin K epoxide reductase complex subunit 1 Interaction
Drug-target interaction between warfarin and vitamin K epoxide reductase complex subunit 1. Synthetic organic pharmacological agent targeting this protein.
yohimbine — α2A-adrenoceptor Interaction
Drug-target interaction between yohimbine and α2A-adrenoceptor. Natural product pharmacological agent targeting this protein.
yohimbine — α2B-adrenoceptor Interaction
Drug-target interaction between yohimbine and α2B-adrenoceptor. Natural product pharmacological agent targeting this protein.
yohimbine — α2C-adrenoceptor Interaction
Drug-target interaction between yohimbine and α2C-adrenoceptor. Natural product pharmacological agent targeting this protein.
zafirlukast — CysLT1 receptor Interaction
Drug-target interaction between zafirlukast and CysLT1 receptor. Synthetic organic pharmacological agent targeting this protein.
zileuton — 5-LOX Interaction
Drug-target interaction between zileuton and 5-LOX. Synthetic organic pharmacological agent targeting this protein.
ziprasidone — 5-HT2A receptor Interaction
Drug-target interaction between ziprasidone and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
ziprasidone — 5-HT2C receptor Interaction
Drug-target interaction between ziprasidone and 5-HT2C receptor. Synthetic organic pharmacological agent targeting this protein.
ziprasidone — D2 receptor Interaction
Drug-target interaction between ziprasidone and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
zofenopril — Angiotensin-converting enzyme Interaction
Drug-target interaction between zofenopril and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
zolbetuximab — claudin 18 Interaction
Drug-target interaction between zolbetuximab and claudin 18. Antibody pharmacological agent targeting this protein.
zoledronic acid — farnesyl diphosphate synthase Interaction
Drug-target interaction between zoledronic acid and farnesyl diphosphate synthase. Synthetic organic pharmacological agent targeting this protein.
zolmitriptan — 5-HT1B receptor Interaction
Drug-target interaction between zolmitriptan and 5-HT1B receptor. Synthetic organic pharmacological agent targeting this protein.
zolmitriptan — 5-HT1D receptor Interaction
Drug-target interaction between zolmitriptan and 5-HT1D receptor. Synthetic organic pharmacological agent targeting this protein.
zolpidem — GABAA receptor α1 subunit Interaction
Drug-target interaction between zolpidem and GABAA receptor α1 subunit. Synthetic organic pharmacological agent targeting this protein.
zorifertinib — epidermal growth factor receptor Interaction
Drug-target interaction between zorifertinib and epidermal growth factor receptor. Synthetic organic pharmacological agent targeting this protein.